Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19

Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is being widely used during the COVID-19 pandemic. Passive antibody therapy via plasma or serum has been successfully used to treat in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ripoll, Juan G., van Helmond, Noud, Senefeld, Jonathon W., Wiggins, Chad C., Klassen, Stephen A., Baker, Sarah E., Larson, Kathryn F., Murphy, Brenna M., Andersen, Kylie J., Ford, Shane K., Casadevall, Arturo, Joyner, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862032/
https://www.ncbi.nlm.nih.gov/pubmed/33564204
http://dx.doi.org/10.1016/j.clinmicnews.2021.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862032/
https://www.ncbi.nlm.nih.gov/pubmed/33564204
http://dx.doi.org/10.1016/j.clinmicnews.2021.02.001

Ejemplares similares